Information Provided By:
Fly News Breaks for February 10, 2016
CTIC
Feb 10, 2016 | 06:47 EDT
WallachBeth analyst Bob Ai downgraded CTI BioPharma to Sell with a 0c price target after the FDA put a full clinical hold on pacritinib. The analyst sees no reason to hold the stock. Piper Jaffray this morning also downgraded CTI Biopharma.
News For CTIC From the Last 2 Days
There are no results for your query CTIC